Replies to post #128673 on Biotech Values

[hptaxis]

I was under the impression that more often than not convertible debt is a bad thing for a company. I take this as a bad sign.

[mcbio]

Now is a good time to do it—before investors figure out that Eylea is going to be a commercial dud!

If nothing else, it's wise of them to take advantage of the generous valuation. ; )